Myeloid Therapeutics
Clinical trials sponsored by Myeloid Therapeutics, explained in plain language.
-
New mRNA drug takes on HER2 cancers in first human trial
Disease control Recruiting nowThis early-stage trial is testing a new mRNA-based drug called MT-304, alone or with the immunotherapy nivolumab, in adults with advanced HER2-expressing solid tumors. The main goals are to check safety, find the right dose, and get a first look at whether it shrinks tumors. Abou…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug MT-303 takes on advanced liver cancer in first human trial
Disease control Recruiting nowThis early-phase trial is testing a new drug called MT-303, alone or with two standard cancer drugs, in people with advanced liver cancer that has spread or cannot be removed. The main goals are to check safety, find the right dose, and see early signs of effectiveness. About 70 …
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC